Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,072.92 -35.17 (-3.17%)
Streaming Delayed Price Updated: 2:46 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
News headline image
November 2025 Marks Seven Straight Months of Growth with 154 New Industrial Capital Projects
JACKSONVILLE BEACH, Fla., Dec. 4, 2025 (SEND2PRESS NEWSWIRE) -- Industrial SalesLeads today announced the findings of its November 2025 report on planned capital project spending within the North... 
Via Send2Press
Topics Artificial Intelligence
News headline image
How Is Agilent Technologies' Stock Performance Compared to Other Healthcare Stocks?
Despite Agilent Technologies’ underperformance relative to its industry peers, Wall Street analysts remain moderately optimistic about the stock’s prospects. 
Via Barchart.com
News headline image
As Eli Lilly Cuts Zepbound Prices, Should You Buy, Sell, or Hold LLY Stock?
Eli Lilly has decided to slash prices of its weight loss drug Zepbound, making it more accessible to customers. 
Via Barchart.com
Topics World Trade
News headline image
Eli Lilly Unusual Options Activity ↗
 
Via Benzinga
News headline image
1 Reason to Buy Eli Lilly Hand Over Fist Before the New Year ↗
A key catalyst may be right around the corner. 
Via The Motley Fool
News headline image
Eli Lilly’s Jaypirca Granted Traditional FDA Approval In Treating Certain Cancers ↗
The agency approved the drug for patients who were previously treated with a covalent BTK inhibitor. 
Via Stocktwits
News headline image
My Top 5 Stocks to Buy Now in December (2025) ↗
There is something for everyone in this excellent list of stocks. 
Via The Motley Fool
News headline image
2 Trillion-Dollar Dividend Stocks to Buy and Hold for 10 Years ↗
They are capitalizing on their ability to innovate and rewarding loyal shareholders in the process. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Navellier Ups Energy Exposure, Increases Argan Position to Over $10 Million ↗
AI demand is making energy stocks attractive. 
Via The Motley Fool
Topics Artificial Intelligence Energy Regulatory Compliance
News headline image
The Shifting Tides: How Retail and Institutional Forces Reshape Market Dynamics
As of late 2025, the financial markets are in the midst of a profound transformation, driven by the dynamic and often divergent interplay between institutional behemoths and an increasingly empowered... 
Via MarketMinute
Topics Artificial Intelligence Economy Fraud
News headline image
U.S. Stock Market Finds Its Footing: A Cautious Ascent After Tariff Shocks and AI Volatility
The U.S. stock market is currently navigating a period of cautious optimism, working to regain solid ground after a tumultuous year marked by significant losses in early 2025 and persistent concerns... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
If You Invested $100 In Eli Lilly Stock 5 Years Ago, You Would Have This Much Today ↗
 
Via Benzinga
News headline image
5 Healthcare Names to Watch as Sector Rotation Is in Full Swing ↗
Via MarketBeat
News headline image
Fundstrat's Tom Lee Predicts S&P 500 Could Climb To 7,300 In December: Report ↗
Lee also cited the end of the Federal Reserve’s quantitative tightening program, effective December 1, as a tailwind for U.S. equity markets. 
Via Stocktwits
Topics Economy Stocks
News headline image
Eli Lilly Cuts Prices For Weight Loss Drug Zepbound To $299 A Month As It Takes On Novo Nordisk’s Wegovy ↗
Patients can buy Zepbound at these prices through the company’s direct-to-consumer platform, LillyDirect. 
Via Stocktwits
Topics Economy Government
News headline image
Trillion-Dollar Companies Now Go To 11; Google Is No. 3 ↗
Eli Lilly recently gained a trillion-dollar valuation. S&P 500 titans Nvidia leads 
Via Investor's Business Daily
Topics Stocks
News headline image
Novo Nordisk's Latest Clinical Result Is Sending the Stock Plunging. Here's What Investors Need to Know. ↗
A promising obesity and diabetes drug stumbles in Alzheimer's trials, rattling markets. Did investors overreact, or is this a reset for long-term opportunity? 
Via The Motley Fool
News headline image
Is the Vanguard Dividend Appreciation ETF a Buy Now? ↗
The Vanguard Dividend Appreciation ETF is a popular choice among dividend investors. 
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
Walmart Will Make Stock Market History on Dec. 9 -- and It Can Top This Feat in 2026 ↗
The puzzle pieces are in place for the world's largest retailer by revenue to reach a milestone in 2026 that only a dozen public companies globally have achieved. 
Via The Motley Fool
Topics Artificial Intelligence Bonds Economy
News headline image
3 Vanguard ETFs to Buy and Hold for the Long Haul ↗
These stocks can be set-it-and-forget-it holdings for most investors. 
Via The Motley Fool
Topics ETFs Economy
News headline image
Should You Invest in This Under-the-Radar Weight Loss Stock? ↗
This small-cap drugmaker just soared on positive clinical trial data, but should you jump on the bandwagon? 
Via The Motley Fool
News headline image
3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio ↗
If you buy companies with in-demand products and hold for the long term, you can end up with long-term winners. 
Via The Motley Fool
News headline image
3 Growth ETFs to Buy With $5,000 and Hold Forever ↗
If you don't want to invest in individual growth stocks, these ETFs could be worth a second look. 
Via The Motley Fool
Topics ETFs
News headline image
Why Novo Nordisk Stock Just Hit a 4-Year Low ↗
Novo Nordisk's drug trial failure is the latest in a series of 2025 woes for the company. 
Via The Motley Fool
News headline image
Is Eli Lilly a Millionaire Maker? ↗
Things are changing rapidly in the pharmaceutical sector, but Eli Lilly remains in the pole position in weight loss drugs. 
Via The Motley Fool
Topics ETFs Intellectual Property
News headline image
These Are 2 of the Smartest Growth Stocks to Invest $5,000 in Today ↗
These top growth stocks are worth a second look. 
Via The Motley Fool
MarketBeat Week in Review – 11/24 - 11/28 ↗
Via MarketBeat
News headline image
Top S&P500 movers in Friday's session ↗
Let's delve into the developments on the US markets one hour before the close of the markets on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
News headline image
These S&P500 stocks are moving in today's session ↗
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday. 
Via Chartmill
News headline image
Beyond the Giants: Gauging Emerging Large-Cap Leadership Amidst Broadening Market Dynamics
The financial markets in late 2025 are signaling a significant, albeit cautious, shift away from the concentrated leadership that has defined much of the past two years. For an extended period, market... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.